Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Contingency [Line Items]
Deferred tax assets, valuation allowance	$ 10,618,000	$ 2,998,000
Change in valuation allowance	$ 7,600,000
Percentage of federal net operating losses used to offset of future taxable income	80.00%
Net operating loss carryforwards	$ 35,300,000
Penalties and Interest Accrued	0
Federal [Member]
Income Tax Contingency [Line Items]
Tax credit carryforward	800,000
California Research and Development [Member]
Income Tax Contingency [Line Items]
Tax credit carryforward	$ 600,000
Research and development credit carryforwards under internal revenue code description	The federal research and development tax credits begin to expire in 2038 unless previously utilized. The California research and development tax credits carry forward indefinitely.Pursuant to the Internal Revenue Code (IRC) Sections 382 and 383, annual use of the Company’s NOL and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. The Company has not completed an ownership change analysis pursuant to IRC Section 382.
Federal [Member]
Income Tax Contingency [Line Items]
Tax loss carryforwards	$ 35,300,000
State [Member]
Income Tax Contingency [Line Items]
Tax loss carryforwards	$ 35,300,000
Net operating loss carryforwards, expire date	Unless previously utilized, the state net operating losses will begin to expire in 2038.